These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28589154)

  • 1. Prolonged Ketosis in a Patient With Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin.
    Pujara S; Ioachimescu A
    J Investig Med High Impact Case Rep; 2017; 5(2):2324709617710040. PubMed ID: 28589154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Euglycemic Diabetic Ketoacidosis with Elevated Acetone in a Patient Taking a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor.
    Andrews TJ; Cox RD; Parker C; Kolb J
    J Emerg Med; 2017 Feb; 52(2):223-226. PubMed ID: 27717592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Induced Euglycemic Diabetic Ketoacidosis: When to Stop the Drip.
    Zughaib MT; Patel K; Leka M; Affas S
    Cureus; 2022 Jan; 14(1):e21768. PubMed ID: 35251838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Euglycemic diabetic ketoacidosis caused by dapagliflozin: A case report.
    Chou YM; Seak CJ; Goh ZNL; Seak JC; Seak CK; Lin CC
    Medicine (Baltimore); 2018 Jun; 97(25):e11056. PubMed ID: 29923997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketoacidosis with euglycemia in a patient with type 2 diabetes mellitus taking dapagliflozin: A case report.
    Yeo SM; Park H; Paek JH; Park WY; Han S; Park SB; Jin K
    Medicine (Baltimore); 2019 Jan; 98(3):e14150. PubMed ID: 30653152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Euglycemic Diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 Canagliflozin.
    Kelmenson DA; Burr K; Azhar Y; Reynolds P; Baker CA; Rasouli N
    J Investig Med High Impact Case Rep; 2017; 5(2):2324709617712736. PubMed ID: 28634592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Euglycemic Diabetic Ketoacidosis in the Setting of SGLT2 Inhibitor Use and Hypertriglyceridemia: A Case Report and Review of Literature.
    Gajjar K; Luthra P
    Cureus; 2019 Apr; 11(4):e4384. PubMed ID: 31218148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature.
    Diaz-Ramos A; Eilbert W; Marquez D
    Int J Emerg Med; 2019 Sep; 12(1):27. PubMed ID: 31488052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium-glucose co-transporter-2 inhibitor-associated euglycemic diabetic ketoacidosis that prompted the diagnosis of fulminant type-1 diabetes: A case report.
    Yasuma T; Okano Y; Tanaka S; Nishihama K; Eguchi K; Inoue C; Maki K; Uchida A; Uemura M; Suzuki T; D'Alessandro-Gabazza CN; Gabazza EC; Yano Y
    World J Clin Cases; 2021 May; 9(13):3163-3169. PubMed ID: 33969104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Euglycemic diabetic ketoacidosis induced by sodium-glucose cotransporter 2 inhibitor in the setting of prolonged fasting: a case report.
    Alkatheeri A; Alseddeeqi E
    J Med Case Rep; 2022 Mar; 16(1):138. PubMed ID: 35346357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium-Glucose Cotransporter 2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: The Other Side of the Coin!
    Kamath SD; Kumar U; Shrivastava V
    Cureus; 2024 Apr; 16(4):e58341. PubMed ID: 38756291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Normal but Catastrophic" Euglycemic Diabetic Ketoacidosis Precipitated by Sodium-Glucose Cotransporter-2 Inhibitor Use: A Case Report.
    Sarno MJF; Hernandez DPF; Matulac MO
    Cureus; 2023 Nov; 15(11):e49236. PubMed ID: 38143642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors be avoided in Covid-19 and other acute Infections?
    Pilianidis G; Papanastasiou G; Tikoudi P; Themistocleous A; Farmakis G; Dolianitis K
    Eur J Case Rep Intern Med; 2024; 11(3):004282. PubMed ID: 38455692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Case of Prolonged Recovery for Post-percutaneous Coronary Intervention (PCI) Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis in a 28-Year-Old.
    Petersen C; Gyabaah F; Sotelo J; Yohanna S; Deoker A
    Cureus; 2023 Sep; 15(9):e45180. PubMed ID: 37842482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dapagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient Presenting with Acute Pancreatitis.
    Badwal K; Tariq T; Peirce D
    Case Rep Endocrinol; 2018; 2018():6450563. PubMed ID: 30159178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case of SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis Following Coronary Artery Bypass Surgery.
    Osafehinti DA; Okoli OJ; Karam JG
    AACE Clin Case Rep; 2021; 7(1):20-22. PubMed ID: 33851014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Literature Review of the Therapeutic Perspectives of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis.
    Patel K; Nair A
    Cureus; 2022 Sep; 14(9):e29652. PubMed ID: 36320965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Euglycemic Ketoacidosis in a Patient without Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors for Heart Failure.
    Miyazaki M; Nakano M; Takahashi H; Isaka Y; Hiura Y
    Am J Case Rep; 2024 Jul; 25():e943945. PubMed ID: 38985686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Euglycemic Diabetic Ketoacidosis Due to SGLT2 Inhibitor in a Patient With Gitelman Syndrome: A Therapeutic Dilemma.
    Ahmed T; Karimi H; Hegde V; Lodhi SH
    Cureus; 2021 Oct; 13(10):e19169. PubMed ID: 34873512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapagliflozin-induced Late-onset Euglycemic Diabetic Ketoacidosis.
    Iqbal I; Hamid M; Khan MAA; Kainat A; Tariq S
    Cureus; 2019 Nov; 11(11):e6089. PubMed ID: 31857921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.